Product Overview
Cagrilintide is a long-acting amylin analog peptide designed to treat obesity and type 2 diabetes by promoting satiety, reducing appetite, and slowing gastric emptying. It is often combined with semaglutide (forming "CagriSema") to enhance weight loss and glycemic control.
*PRODUCT USAGE: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals/ This product is not a drug, food or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
